藥物成份

共有 21645 個藥物成份

Potassium Chloride contains NLT 99.0% and NMT 100.5% of KCl, calculated on anhydrous substance.

• 關聯藥證數量: 1

Potassium Chloride contains not less than 99.0% and not more than 100.5% of KCl, calculated on the dried substance.

• 關聯藥證數量: 1

Potassium Chloride, 1.0 mol/L, Preservative

• 關聯藥證數量: 1

Potassium Cresolsulfonate contains 98.5% ~ 101.0% of Potassium Cresolsulfonat (C7H7KO4S), calculated on the dried basis.

• 關聯藥證數量: 1

Potassium Cyanide 5.5 g/l\nSodium Nitroprusside 0.5 g/l

• 關聯藥證數量: 1

Potassium Cyanide...............< 0.03 %、\nQuaternary Ammonium Salts...............< 2.67 %

• 關聯藥證數量: 1

Potassium Guaiacolsulfonate contains 98.5%~101.0% of Potassium Guaiacolsulfonate (C7H7KO5S), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Potassium Guaiacolsulfonate contains not less than 98.0 per cent and not more than 102.0 per cent of C7H7KO5S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Potassium Guaiacolsulfonate contains not less than 98.0 percent and not more than 102.0 percent of C7H7KO5S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Potassium Guaiacolsulfonate contains not less than 98.0 percent and not more than 102.0 percent of C7H7KO5S, calculated on the dried basis.

• 關聯藥證數量: 1

Potassium Hydroxide 416 mmol/L

• 關聯藥證數量: 1

Potassium Iodide contains not less than 99.0% and not more than 100.5% of KI (Calculated or dried substance)

• 關聯藥證數量: 1

Potassium Metaborate

• 關聯藥證數量: 1

Potassium Sorbate.....1.3mg;\nSodium Chloride.....5.0mg;\nEdetate Disodium.....2.0mg;\nTriton X-405.....2.5mg;\nP.V.P.-K90.....8.0mg;\nBoric Acid.....6.77mg;\nSodium Borate.....1.7008mg;\nWater for injection added to make.....1ml\n以下空白

• 關聯藥證數量: 1

Potassium and Magnesium L-Aspartate (equal mixture)

• 關聯藥證數量: 1

Potassium diclofenac contains not less than 99.0% and not more than the equivalent of 101.0% C14H10Cl2KNO2, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Potassium ferricyanide 180 μg and butyrylthiocholine iodide 290 μg.

• 關聯藥證數量: 1

Potassium iodide 30 mmol/l\nPotassium sodium tartrate 32 mmol/l\nCopper sulphate 18 mmol/l\nSodium hydroxide 200 mmol/l\nAlbumin Bovine Fraktion V 6g/100ml

• 關聯藥證數量: 1

Potato starch、Glycerol、Whole egg、Monopotassium phosphate、Magnesium sulfate、Magnesium citrate、L-asparagine、Malachite green.

• 關聯藥證數量: 1

Povidone-Iodine 9-12%

• 關聯藥證數量: 1

Povidone-Iodine is a complex of Iodine with Povidone. It contains not less than 9.0% and not more than 12.0% of available iodine (I), calculated on the dried basis.

• 關聯藥證數量: 1

Povidone-Iodine is a complex of lodine with Povidone. It contains not less than 9.0% and not more than 12.0% of available iodine (I), calculated on the dried basis.

• 關聯藥證數量: 1

Povidone.........................2mg\nSorbic Acid.....................1mg\nBoric Acid.......................1.7mg\nSodium Borate.................2.2mg\nSodium Chloride...............5mg\nPotassium Chloride..........2.1mg\nEdetate Disodium.............1mg\nWater Purified add to .......1mL\n以下空白\n

• 關聯藥證數量: 1

Povidone.....12.5%\nPotassium chloride.....2.1%\nSodium borate.....2.2%\nBoric acid.....1.7%\nEdentate disodium.....1%\nSorbic acid.....1%\n1N Hydrochloride acid…as needed for pH adjustment \n1N Sodium hydroxide…as needed for pH adjustment\n以下空白

• 關聯藥證數量: 1

Powdered Citrus Unshiu Peel

• 關聯藥證數量: 1

Powdered Magnolia Bark

• 關聯藥證數量: 1

Powdered Rose Fruit

• 關聯藥證數量: 1

Powdered Smilax Rhizome

• 關聯藥證數量: 1

Pralatrexate

• 關聯藥證數量: 1

Pralidoxime Chloride contains not less than 97.0% and not more than 102.0% of C7H9ClN2O, calcualted on the dried basis.

• 關聯藥證數量: 1

Pramipexole Dihydrochloride Monohydate contains not less than 98.0% and not more than 101.0% of C10H17N3S‧2HCl‧H2O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Pramipexole HCl (Pramipexole Di-HCl Monohydrate) contains not less than 98.0% and not more than 102.0% of C10H19Cl2N3S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Pravastatin Sodium contains not less than 97.0 percent and not less than 97.0 percent and not more than 102.0 percent (anhydrous substance)

• 關聯藥證數量: 1

Pravastatin Sodium contains not less than 97.0% and not more than 102.0% of C23H35NaO7 calculated on anhydrous and ethanol-free substance.

• 關聯藥證數量: 1

Pravastatin Sodium contains not less than 97.0% and not more than 102.0% of C23H35NaO7, calculated on dried basis.

• 關聯藥證數量: 1

Pravastatin sodium contains not less than 97.0% and not more than 102.0% of C23H35NaO7, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Prazosin HCl contains the equivalent of not less than 97.0% and not more than 103.0% of C19H21N5O4 HCl.

• 關聯藥證數量: 1

Pre-Amplifier Probes (1x130mL): synthetic oligonucleotides, buffered solution, sodium azide (< 0.1%), preservatives\nAmplifier Probe (1x130mL): synthetic oligonucleotides, buffered solution, sodium azide (< 0.1%), preservatives\nSubstrate (1x12mL): chemiluminescent substrate (Lumi-Phos&reg; Plus)\nSubstrate Enhancer (1x1.2mL): aqueous solution, sodium azide (< 0.1%), preservatives\n

• 關聯藥證數量: 1

Pre-Trigger Solution: 1.32% (w/v) hydrogen peroxide \nTrigger Solution: 0.35 N sodium hydroxide\nWASH BUFFER: phosphate buffered saline solution

• 關聯藥證數量: 1

Pre-optimized and tested mixture of microspheres with probes covalently attached\nHybridization reaction buffers to facilitate the binding of target DNA to the probe\nWash Buffer to wash off unbound DNA\nSAPE buffer for diluting Stock SAPE solution\nDNA amplification reagents(pre-optimized HLA loci-specific primer mix)\nD-mix (specially formulated amplification).

• 關聯藥證數量: 1

PreciControl ACTH\n？PC ACTH1: 2 bottles, each for 2.0 mL of control serum\n？PC ACTH2: 2 bottles, each for 2.0 mL of control serum\nACTH (synthetic) in two concentration ranges (approx. 100pg/mL and approx. 1000 pg/mL) in an equine serum matrix.

• 關聯藥證數量: 1

PreciControl Toxo IgG\nReagents - working solutions\n？PC TOXIGG1: 8 bottles, each containing 1.0 mL of control serum Human serum, negative to low positive for Toxo IgG antibodies (approx. 1 IU/mL); preservative.\n？PC TOXIGG2: 8 bottles, each containing 1.0 mL of control serum Human serum, positive for anti-Toxo IgG antibodies (approx. 50 IU/mL); preservative.

• 關聯藥證數量: 1

PreciControl\n？PC RUBIGG1: 8 bottles, each containing 1.0 mL of control serum\nHuman serum, negative to low positive for Rubella IgG antibodies\n(approx. 4 IU/mL); preservative.\n？PC RUBIGG2: 8 bottles, each containing 1.0 mL of control serum\nHuman serum, positive for anti-Rubella IgG antibodies\n(approx. 75 IU/mL); preservative.

• 關聯藥證數量: 1

PreciControl：\nPC Thyro1: 1 bottle, for 2.0 mL of control serum\nAnti-TSHR antibody (human) approx. 4 IU/L in a human serum matrix.\nPC Thyro2: 1 bottle, for 2.0 mL of control serum\nAnti-TSHR antibody (human) approx. 16 IU/L in a human serum matrix.

• 關聯藥證數量: 1

PreciNeg: Benzodiazepines (nordiazepam), Cannabinoids (Δ9-THC-COOH), and Opiates (d-morphine) PreciPos: Benzodiazepines (nordiazepam), Cannabinoids (Δ9-THC-COOH), and Opiates (d-morphine)

• 關聯藥證數量: 1

Precipitant: Dextran Sulfate 10g/L, Magnesium sulfate 0.5 mol/L, Sodium Azide 0.025% Calibrator A: Cholesterol 50 mg/dL, Sodium Azide 0.1% Calibrator B: Cholesterol 100 mg/dL, Sodium Azide 0.1%\n

• 關聯藥證數量: 1

Preciset TDM I calibrators contain the following therapeutic drugs (A-F)：\nDigoxin：0-5 ng/mL\nCarbamazepine：0-20 ug/mL\nGentamicin：0-10 ug/mL\nPhenobarbital：0-60 ug/mL\nPhenytoin：0-40 ug/mL\nPrimidone：0-24 ug/mL\nTheophylline：0-40 ug/mL\nTobramycin：0-10 ug/mL\nValproic Acid：0-150 ug/mL\nVancomycin：0-80 ug/mL

• 關聯藥證數量: 1

Preciset TDM II calibrators contain the following therapeutic drugs: Digitoxin, Amikacin, Lidocaine, NAPA, Procainamide, Quinidine.

• 關聯藥證數量: 1

Precision-Rate&reg; is made up of stabilized red cells suspended in a buffered solution and preservatives.

• 關聯藥證數量: 1

Prednisolone Acetate contains not less than 97.0% and not more than 102.0% of C23H30O6, calculated on the drid basis.

• 關聯藥證數量: 1

Prednisolone Acetate contains not less than 97.0% and not more than 103.0% of C23H30O6, calculated on dried substance.

• 關聯藥證數量: 1

Prednisolone Acetate contains not less than 97.0% and not more than 103.0% of C23H30O6, calculated on the dried substance.

• 關聯藥證數量: 1

Prednisolone Sodium Phosphate contains not less than 96.0 % and not more than 102.0 % of C21H27Na2O8P, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Prednisolone Sodium Phosphate contains not less than 96.0% and not more than 102.0% of C21H27Na2O8P, calculated on the dried basis.

• 關聯藥證數量: 1

Prednisolone Sodium Phosphate contains not less than 96.0% to 103.0% of C21H27Na2O8P calculated on the dried basis.

• 關聯藥證數量: 1

Prednisolone according to USP(Prednisolone contains not less than 97.0 percent and not more than 102.0 percent of C21H28O5, calculated on the dried basis.)

• 關聯藥證數量: 1

Prednisolone acetate contains not less than 97.0% and not more than the equivalent of 103.0% of C23H30O6, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Prednisolone atetate contains not less than 97.0% and not more than 102.0% of C23H30O6, calculated on the dried basis.

• 關聯藥證數量: 1

Prednisolone contains not less than 96.5% and not more than 102.0% of C21H28O5, calculated on the dried substance.

• 關聯藥證數量: 1

Prednisolone contains not less than 97.0 % and not more than 102.0 % of C12H28O5, calculated on the dried basis.

• 關聯藥證數量: 1

Prednisolone contains not less than 97.0 % and not more than 103.0% of C21H28O5,calculated on the dried basis.

• 關聯藥證數量: 1

Prednisolone contains not less than 97.0% and not more than 102% of C21H28O5 (dried substance) (USP)

• 關聯藥證數量: 1

Prednisolone contains not less than 97.0% and not more than the equivalent of 103.0% of C21H28O5, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Prednisolone contains not less than 97.0% and not more than the equivalient of 103.0% of C21H28O5 calculated with reference to the dried substance.

• 關聯藥證數量: 1

Prednisolone\nContains not less than 97.0% and not more than 102.0% of C21H28O5, calculated on the dried basis.

• 關聯藥證數量: 1

Pregabalin Content:98.0 percent to 102.0 percent (anhydrous substance).

• 關聯藥證數量: 1

Pregabalin contains not less than 98.0% and not more than 101.0% of C8H17NO2, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Pregabalin contains not less than 98.0% and not more than 102.0% of C8H17NO2, calculated on anhydrous substance.

• 關聯藥證數量: 1

Pregabalin contains not less than 98.0% and not more than 102.0% of C8H17NO2, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Pregabalin contains not less than 98.0% and not more than 102.0% of C8H17NO2, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Pregabalin, Not less than 98.0% and Not more than 102.0% w/w.

• 關聯藥證數量: 1

Preservative

• 關聯藥證數量: 1

Pretreatment rackpack\nPT1 Pretreatment buffer solution, 1 bottle, 4 mL:\nPhosphate buffer 20 mmol/L, pH 7.4; stabilizers; preservative.\nPT2 Empty bottle for pretreatment reagent (PTR)\nreconstituted with pretreatment buffer (PTB)\nPTR Pretreatment reagent, pTSHR-anti-pTSHR-Ab~biotin complex\n1 bottle for 4 mL of PTB:\nPhosphate buffer 40 mmol/L, pH 7.2; stabilizers.\nPTB Pretreatment buffer 1 bottle, 5 mL:\nReconstitution medium for PTR; phosphate buffer\n10 mmol/L, pH 7.2; stabilizer.

• 關聯藥證數量: 1

Prilocaine contains 99.0 per cent to 101.0 per cent (anhydrous substance) of C13H20N2O.

• 關聯藥證數量: 1

Prilocaine contains not less than 98.0% and not more than 102.0% of C13H20N2O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Prilocaine contains not less than 99.0 % and not more than 101.0 % of C13H20N2O, calculated on anhydrous substance.

• 關聯藥證數量: 1

Prilocaine contains not less than 99.0% and not more than 101.0% of C13H20N2O calculated on the anhydrous substance.

• 關聯藥證數量: 1

Primidone contains not less than 98.0% and not more than 102.0% of C12H14N2O2 calculated on the dried basis.

• 關聯藥證數量: 1

Primidone contains not less than 98.0% and not more than 102.0% of C12H14N2O2, calculated on the dried basis.

• 關聯藥證數量: 1

Primjel

• 關聯藥證數量: 1

Probe Reagent : Mycobacterium intracellulare. \nLysing Reagent : Glass beads and buffer. \nReagent 1 (Lysis Reagent) : buffered solution containing 0.04% sodium azide. \nReagent 2 (Hybridization Buffer) : buffered solution. \nReagent 3 (Selection Reagent) : buffered solution. \nDetection Reagent I : 0.1% hydrogen peroxide in 0.001 N nitric acid. \nDetection Reagent II : 1 N sodium hydroxide.

• 關聯藥證數量: 1

Probe Reagent\nMycobacterium kansasii.\nLysing Reagent \nGlass beads and buffer.\nReagent 1 (Lysis Reagent)\nbuffered solution containing 0.04% sodium azide.\nReagent 2 (Hybridization Buffer)\nbuffered solution.\nReagent 3 (Selection Reagent)\nbuffered solution.\nDetection Reagent I\n0.1% hydrogen peroxide in 0.001 N nitric acid.\nDetection Reagent II\n1N sodium hydroxide.\n\n

• 關聯藥證數量: 1

Probe Rinse：Surfactants and stabilizers necessary for optimun system operation.

• 關聯藥證數量: 1

Procaine Hydrochloride contains not less 99.0 percent and not more than the equivalent of 101.0 percent of C13H2ON2O2HCl, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Procaterol Hydrochloride Hemihydrate contains not less than 98.5% of C16H22N2O3？HCl, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Procell 6x380ml contents phosphate buffer 300mmol/l, tripropylamine 180mmol/l, detergent<=0.1%, pH6.8. Cleancell 6x380ml contents KOH 176 mmol/l, detergent<=1%, PH13.2Diluent universal 2x18ml, contents protein matrix.

• 關聯藥證數量: 1

Procell elecys 6x380ml, 含 phosphate buffer 300mmol/l, tripropylamine 180mmol/l, detergent<=0.1%, preservative PH6.8.Cleancell elecys 6x380ml, 含 KOH 176 mmol/l, detergent<=1%, PH13.2Diluent universal 1x18ml, 含 protein matrix

• 關聯藥證數量: 1

Procell elecys 6x380ml, 含 phosphate buffer 300mmol/l, tripropylamine 180mmol/l, detergent<=0.1%, preservative PH6.8.Cleancell elecys 6x380ml, 含 KOH 176 mmol/l, detergent<=1%, PH13.2Diluent universal 2x18ml, 含 protein matrix.

• 關聯藥證數量: 1

Produced in rabbits and preserved with 0.5% phenol.

• 關聯藥證數量: 1

Progesterone Bead Pack (L2PW12)\nbead coated with polyclonal rabbit anti-progesterone.\nProgesterone Reagent Wedge (L2PWA2)\n18.5 mL alkaline phosphatase (bovine calf intestine) conjugated to progesterone, in buffer.\nProgesterone Adjustors (LPWL, LPWH)\nTwo vials (Low and High), 3 mL each, of progesterone in processed human serum, with preservative.

• 關聯藥證數量: 1

Progesterone Maia Tracer：contains I-125 labeled Progesterone derivative in 12.5ml\nPhosphate-citrate buffer with bovine serum albumin.\nProgesterone Maia Calibrators：contain respectively：0-0.15-0.5-1.5-5-15-50 ng/ml (0-0.477-1.59-4.77-15.9-47.7-159 nmol/l) of progesterone in human and horse serum matrix buffered with tris <0.1%w/w.1 ml for the zero standard,0.5 ml for each of the remaining standards.\nProgesterone Maia Separation Reagent：contains goat anti-rabbit gammaglobulin coupled to magnetic particles in tris buffer with bovine serum albumin.\nProgesterone Maia Antiserum：contains rabbit anti-progesterone in aqueous solution with rabbit gammaglobulins, bovine serum albumin.\nSerotest S：The vial contains lyophilized control serum containing human serum.\n

• 關聯藥證數量: 1

Progesterone Standards: \nOne vial, labeled A, containing 0 ng/mL and five vials, labeled B-F, containing concentrations of\napproximately 0.3, 1.0, 5.0, 20.0, and 60.0 ng/mL (1.0-190.8 nmol/L) of progesterone in serum with sodium\nazide as a preservative. \n* DSL-3900 (500 Tubes) contains three sets of Standards.\nProgesterone [I-125] Reagent: \nOne bottle (DSL-3900), 55 mL each, containing <5 μCi (185 kBq) of [I-125]-labeled progesterone in a\nprotein-based buffer with sodium benzoate as a preservative. \n* DSL-3900 (500 Tubes) contains five vials of reagent.\nAnti-Progesterone-Coated Tubes: \n

• 關聯藥證數量: 1

Progesterone contains not less than 97.0% and not more than 102.0% of C21H30O2, calculated on the dried basis.

• 關聯藥證數量: 1

Progesterone contains not less than 97.0% and not more than 103.0% of C21H30O2, calculated on the dried basis.

• 關聯藥證數量: 1

Progesterone contains not less than 97.0% and not more than 103.0% of C21H30O2.

• 關聯藥證數量: 1

Progesterone, when calculated on the dried substance, contains not less than 97.0% and not more than 103.0% of C21H30O2.

• 關聯藥證數量: 1

Prokaryotic recombinant protein corresponding to the full length alpha form of the human estrogen receptor molecule.

• 關聯藥證數量: 1

Prolactin Bead Pack (L2PR12): coated with monoclonal murine anti-prolactin.\nProlactin Reagent Wedge (L2PRA2): alkaline phosphatase conjugated to polyclonal goat anti-prolactin.\nProlactin Adjustors (LPRL, LPRH): lyophilized human prolactin in a serum / buffer matrix.

• 關聯藥證數量: 1

Prolactin Standards: One vial, labeled A, containing 0 ng/mL and five vials, labeled B-F, containing concentrations of approximately 2.0, 6.0, 20.0, 60.0, and 180.0 ng/mL prolactin in a porcine serum with sodium azide as a preservative.*DSL-4500 (500 tubes) contains three sets of Standards.Active Prolactin [I-125] Reagent: One bottle, 22 mL each, containing < 10 μCi (370 kBq) of [I-125]-labeled anti-prolactin antibody in a protein-based (BSA) buffer with sodium azide as a preservative.*DSL-4500 (500 tubes) contains five bottles of reagent. Anti- Prolactin -Coated Tubes: One hundred (100) plastic tubes with anti-prolactin antibody immobilized to the inside wall of each tube.*DSL-4500 (500 tubes) contains five hundred (500) plastic tubes. Prolactin Controls: Two vials, Level I and II, containing low and high concentrations of prolactin in a porcine serum with sodium azide as a preservative.*DSL-4500 (500 tubes) contains three sets of cntrols. Wash Contration: One bottle, 18 mL each,containin

• 關聯藥證數量: 1

Prolactin reagent M Streptavidin-coated microparticles(transparent cap),1 bottle, 6.5 mL： Streptavidin-coated microparticles,0.72 mg/mL;binding capacity： 470 ng biotin/mg microparticles R1 Anti-prolactin-Ab~biotin (gray cap),1 bottle,10 mL：Biotinylated monoclonal anti-prolactin antibody (mouse) 1.6 mg/mL;phosphate buffer 50 mmol/L,pH7.0 R2 Anti-prolactin-Ab~Ru(bpy)3 2+(black cap), 1 bottle,10 mL：Monoclonal anti-prolactin antibody(mouse)labeled wuth ruthenium complex 0.3 mg/mL;phosphate buffer 50 mmol/L,pH7.0 Prolactin Calset ？PRL Cal1 and 2：2 bottles, each for 1.0 mL of calibrator 1 and 2 Prolactin (human, recombinant, from E.coli) in two concentration ranges(approx. 2uIU/mL or 0.09 ng/mL and approx. 2000 ulIU/mL or 94 ng/mL) in a buffer/protein matrix

• 關聯藥證數量: 1